Description
Oncologic emergencies require rapid recognition and timely management to improve patient outcomes. This session will provide a practical overview of common emergencies such as tumor lysis syndrome, spinal cord compression, and febrile neutropenia. Emphasis will be placed on early warning signs, diagnostic approach, and evidence-based management. Through clinical insights, participants will learn how to make quick and effective decisions in acute settings. This webinar is designed to enhance confidence in handling critical situations in oncology practice.
Summary Listen
- Oncological emergencies demand prompt and effective intervention, as the initial treatment significantly impacts the patient's long-term outcome and quality of life. Spinal cord compression, a critical emergency, requires timely diagnosis via MRI and urgent radiation treatment to prevent permanent neurological dysfunction. Ideally, decompression should occur within 72 hours to maximize the chances of regaining ambulation.
- Spinal cord compression can stem from tumor growth, hematomas, or abscesses. Prognosis varies depending on the tumor type and patient's overall health. Favorable tumor types like breast, prostate, lymphoma, seminoma, and myeloma often respond well to chemo and radiotherapy. Unfavorable tumor types like melanoma, lung cancer, sarcoma, and gastrointestinal cancers may require more aggressive interventions, including surgery. Time is crucial for better outcomes.
- MRI is the preferred diagnostic tool for spinal cord compression due to its high sensitivity and specificity. If MRI is unavailable, CT myelography can be considered. When metastatic disease is unproven, a tissue smear should be taken to rule out non-malignant conditions. Steroids can be administered to reduce inflammation, but they should be avoided in suspected lymphoma cases. Surgical decompression combined with radiotherapy yields better outcomes and quality of life for patients with a life expectancy exceeding 3 months.
- Brain metastases pose another oncological emergency. The choice of treatment depends on the number and location of metastases. Stereotactic radiosurgery is often preferred for oligometastatic disease, while whole-brain radiotherapy is used for multiple metastases. Newer systemic therapies are also crossing the blood-brain barrier, necessitating a combined decision-making approach between surgeons, radiation oncologists, and medical oncologists.
- Superior vena cava (SVC) syndrome, often associated with lung cancer and lymphoma, manifests as facial swelling, dyspnea, and arm swelling. Management includes diuretics, steroids, and sometimes thrombolytic therapy for clots. Chemotherapy and radiation are common treatment modalities, and SVC stenting may be necessary in certain cases.
- Febrile neutropenia, a common complication of chemotherapy, requires immediate broad-spectrum antibiotics and potentially antifungal treatment. Cultures should be obtained, but treatment should not be delayed pending results. Colony-stimulating factors can aid in neutrophil recovery. Risk stratification guides treatment intensity.
- Hypercalcemia, frequently seen in patients with bone metastases, can cause various symptoms, including pain, confusion, and kidney stones. Management involves bisphosphonates, denosumab, and addressing the underlying tumor. Tumor lysis syndrome, characterized by elevated uric acid and potassium levels, is a risk in patients with high tumor burden malignancies like acute leukemia and lymphoma. Prophylactic measures, including hydration and allopurinol or rasburicase, are crucial for preventing this potentially life-threatening condition.
Sample Certificate
About the Speakers
Dr. Sairam Chinthamadaka
Director and Senior Consultant Oncologist, Senior Cancer Specialist, Hon. Secretary IMA AMS Hqrs (2024-26), Vice President Zone- 1, IMA TS (2024-25)
Comments
Comments
You must be logged in to leave a comment.